Choosing Between AWS HealthOmics and Managed Slurm for Bioinformatics
AWS HealthOmics and managed Slurm solve different problems. Here's an honest comparison to help you pick the right fit for your team's workloads, budget, and growth trajectory.
If you're evaluating compute platforms for bioinformatics, AWS HealthOmics and managed Slurm (like Clusterra) are two fundamentally different approaches. HealthOmics is a fully managed genomics service with zero-config Ready2Run pipelines. Clusterra is a managed Slurm platform that runs Nextflow, MPI, GPU, and batch workloads on AWS Spot instances.
Both are legitimate choices — the right one depends on your team's workloads, budget, and where you're headed. This post lays out the trade-offs honestly.
Where Each Platform Shines
HealthOmics Is Great For
Zero-config genomics. If you want to run a GATK Best Practices pipeline on WGS data, HealthOmics' Ready2Run workflows are genuinely easy. Upload your FASTQ to S3, click run, get a VCF back. No cluster to manage, no instances to configure, no storage to provision.
AWS-native integration. IAM, CloudWatch, S3 — it all works seamlessly. No custom networking needed.
Compliance out of the box. HealthOmics inherits AWS's compliance posture — HIPAA, SOC2, FedRAMP. If you need certifications today, this is a real advantage.
Sequence Store. Purpose-built storage for genomic data with built-in format conversion and annotation. Genuinely useful for teams managing large cohorts.
Clusterra Is Great For
Transparent Spot pricing. Clusterra passes AWS Spot prices directly through — no compute markup. A 10% orchestration fee on the on-demand list price is all you pay on top.
Multi-modal workloads. Run Nextflow pipelines, multi-node MPI (GROMACS, AMBER), GPU jobs (AlphaFold, ML training), and custom batch scripts on a single cluster. One scheduler, one console, one bill.
Slurm familiarity. Most computational biology PhDs learned sbatch in grad school. Clusterra gives them the same interface with managed infrastructure underneath.
Scale-to-zero. Pay $0 when no pipelines are running. Karpenter terminates all worker nodes when the queue is empty.
Pipeline portability. Your Nextflow pipeline with executor = 'slurm' runs on Clusterra, any academic HPC cluster, or your own Kubernetes deployment — no vendor-specific configuration.
Cost Comparison
Different pricing models make direct comparison important. Here's what equivalent compute costs:
| Instance Size | HealthOmics | Clusterra (Spot + fee) | EC2 On-Demand |
|---|---|---|---|
| 4 vCPU, 16 GB | ~$0.50/hr | ~$0.077/hr | $0.192/hr |
| 8 vCPU, 32 GB | ~$1.00/hr | ~$0.153/hr | $0.384/hr |
| 16 vCPU, 64 GB | ~$2.00/hr | ~$0.307/hr | $0.768/hr |
HealthOmics uses proprietary "omics instances" that include infrastructure management in the price. Clusterra uses standard EC2 Spot instances with the management fee separate.
For a 30x WGS pipeline (BWA + GATK): - HealthOmics: ~$10–$15 per sample (Ready2Run pricing) - Clusterra: ~$3.70–$5.10 per sample (Spot)
At 100 samples/month, the difference is meaningful — $1,000–$1,500 vs $370–$510.
Workload Support
This is where the two platforms diverge most. HealthOmics is purpose-built for genomics workflows. Clusterra is a general-purpose Slurm scheduler that handles diverse computational biology workloads.
| Capability | HealthOmics | Clusterra (Managed Slurm) |
|---|---|---|
| Nextflow | Yes | Yes |
| WDL | Yes | Via Cromwell on Slurm |
| Multi-node MPI | No | Yes (native srun) |
| Non-containerized jobs | No | Yes |
| GPU scheduling (GRES) | Limited selection | Any EC2 GPU type |
| Array jobs (docking screens) | No | Yes (--array) |
| Interactive (Jupyter) | No | Yes (srun --pty) |
| Ready2Run pipelines | Yes | No (bring your own) |
If your team only runs Nextflow/WDL genomics pipelines, HealthOmics covers you well. If your team also runs molecular dynamics (GROMACS/AMBER), structure prediction (AlphaFold), or ML training alongside genomics, Clusterra lets you consolidate onto one platform.
Flexibility vs Convenience
HealthOmics optimizes for convenience — AWS manages everything, including instance selection. The trade-off is less control: you can't choose instance types, use Spot/Reserved pricing, or run workloads outside the Nextflow/WDL paradigm.
Clusterra optimizes for flexibility and cost — you get full Slurm capabilities, Spot pricing, and the ability to run any workload. The trade-off is that you bring your own pipelines (no Ready2Run gallery) and compliance certifications are still in progress.
When to Choose Each
Choose HealthOmics when: 1. You only run standard genomics pipelines (WGS, RNA-seq, exome) 2. Compliance certifications are required today (HIPAA, SOC2) 3. You want Ready2Run pipelines with zero configuration 4. Convenience matters more than cost — your team is small and engineering time is expensive
Choose Clusterra when: 1. Cost is a priority — Spot pricing makes a material difference at your volume 2. You run mixed workloads — Nextflow + MPI + GPU on one cluster 3. Your team knows Slurm and wants familiar tooling 4. Pipeline portability matters — no vendor lock-in 5. You need scale-to-zero to avoid idle infrastructure costs
What We're Still Building
Transparency about our gaps: - Compliance certifications (SOC2, HIPAA) — not yet available - Support SLA — Clusterra is a startup; HealthOmics comes with AWS support tiers - Data Studios / interactive analysis — not yet available - Ready2Run pipeline gallery — you bring your own nf-core pipelines
Try Both
The best way to decide is to run the same pipeline on both platforms and compare cost and experience.
Clusterra: Sign up at clusterra.cloud — submit your first pipeline in under 5 minutes. No credit card required.
Built by the former Product Manager for AWS Batch and AWS Parallel Computing Service.
Evaluating compute platforms for bioinformatics? We're happy to help you compare costs on your specific pipelines — hello@clusterra.cloud.